Literature DB >> 23559401

Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI.

Karin Weissenborn1, Eva Bültmann, Frank Donnerstag, Anja M Giesemann, Friedrich Götz, Hans Worthmann, Meike Heeren, Jan Kielstein, Anke Schwarz, Heinrich Lanfermann, Xiao-Qi Ding.   

Abstract

INTRODUCTION: Severe neurological symptoms in Shiga toxin-producing Escherichia coli infection associated hemolytic-uremic syndrome (STEC-HUS) are often accompanied by none or only mild alterations of cerebral magnetic resonance imaging (MRI). This study aims to analyze if quantitative MRI is able to reveal cerebral pathological alterations invisible for conventional MRI.
METHODS: In nine patients with STEC-HUS associated severe neurological symptoms but inconspicuous cerebral MRI findings maps of the parameters T2 relaxation time, relative proton density (PD), apparent diffusion coefficient (ADC), and fractional anisotropy (FA) were generated. Quantitative values of these parameters were measured at the basal ganglia, thalamus, and white matter of the frontal and parietal lobe and compared to those of nine age- and sex-matched controls.
RESULTS: Significant T2 prolongation (p < 0.01) was found in the basal ganglia of all patients compared to controls. PD and ADC were not significantly altered. A significant reduction of FA in patients was seen at caput nuclei caudati (p < 0.01).
CONCLUSION: Prolonged T2 relaxation time indicates cerebral microstructural damages in these patients despite their inconspicuous MRI findings. T2 relaxometry could be used as a complementary tool for the assessment of metabolic-toxic brain syndromes.

Entities:  

Mesh:

Year:  2013        PMID: 23559401     DOI: 10.1007/s00234-013-1176-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  28 in total

1.  Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells.

Authors:  Andreas Bauwens; Martina Bielaszewska; Björn Kemper; Patrik Langehanenberg; Gert von Bally; Rudolf Reichelt; Dennis Mulac; Hans-Ulrich Humpf; Alexander W Friedrich; Kwang S Kim; Helge Karch; Johannes Müthing
Journal:  Thromb Haemost       Date:  2010-12-06       Impact factor: 5.249

2.  Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities.

Authors:  Carla Tironi-Farinati; C Fabián Loidl; Javier Boccoli; Yanil Parma; Mariano E Fernandez-Miyakawa; Jorge Goldstein
Journal:  J Neuroimmunol       Date:  2010-03-27       Impact factor: 3.478

3.  Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement.

Authors:  Frank Donnerstag; Xiaoqi Ding; Lars Pape; Eva Bültmann; Thomas Lücke; Jan Zajaczek; Ludwig Hoy; Anibh Martin Das; Heinrich Lanfermann; Jochen Ehrich; Hans Hartmann
Journal:  Eur Radiol       Date:  2011-10-08       Impact factor: 5.315

4.  Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Authors:  Sylvie Nathanson; Thérésa Kwon; Monique Elmaleh; Marina Charbit; Emma Allain Launay; Jérôme Harambat; Muriel Brun; Bruno Ranchin; Flavio Bandin; Sylvie Cloarec; Guylhene Bourdat-Michel; Christine Piètrement; Gérard Champion; Tim Ulinski; Georges Deschênes
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

5.  Normal brain maturation characterized with age-related T2 relaxation times: an attempt to develop a quantitative imaging measure for clinical use.

Authors:  Xiao-Qi Ding; Thomas Kucinski; Oliver Wittkugel; Einar Goebell; Ulrich Grzyska; Maria Görg; Alfried Kohlschütter; Hermann Zeumer
Journal:  Invest Radiol       Date:  2004-12       Impact factor: 6.016

6.  CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings.

Authors:  Marc Steinborn; Steffen Leiz; Klaus Rüdisser; Martin Griebel; Thomas Harder; Helmut Hahn
Journal:  Pediatr Radiol       Date:  2004-07-29

7.  Clinical applications of quantitative T2 determination: a complementary MRI tool for routine diagnosis of suspected myelination disorders.

Authors:  Xiao-Qi Ding; Oliver Wittkugel; Einar Goebell; Ann-Freya Förster; Ullrich Grzyska; Hermann Zeumer; Jens Fiehler
Journal:  Eur J Paediatr Neurol       Date:  2007-10-26       Impact factor: 3.140

8.  CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis.

Authors:  J F Bale; C Brasher; R L Siegler
Journal:  Am J Dis Child       Date:  1980-09

Review 9.  Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.

Authors:  E G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

10.  Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.

Authors:  Kiyomi Takahashi; Nobuaki Funata; Fusahiro Ikuta; Shigehiro Sato
Journal:  J Neuroinflammation       Date:  2008-03-21       Impact factor: 8.322

View more
  6 in total

Review 1.  Pharmacological MRI (phMRI) of the Human Central Nervous System.

Authors:  H Lanfermann; C Schindler; J Jordan; N Krug; P Raab
Journal:  Clin Neuroradiol       Date:  2015-09-02       Impact factor: 3.649

2.  Detection of Normal Aging Effects on Human Brain Metabolite Concentrations and Microstructure with Whole-Brain MR Spectroscopic Imaging and Quantitative MR Imaging.

Authors:  V V Eylers; A A Maudsley; P Bronzlik; P R Dellani; H Lanfermann; X-Q Ding
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

3.  Involvement of Angiopoietin-2 and Tie2 Receptor Phosphorylation in STEC-HUS Mediated by Escherichia coli O104:H4.

Authors:  Alexander Lukasz; Jan Beneke; Kristina Thamm; Jan T Kielstein; Jan Menne; Jan-Henrik Mikesch; Bernhard M W Schmidt; Hermann Haller; Philipp Kümpers; Sascha David; Mario Schiffer
Journal:  Mediators Inflamm       Date:  2015-12-24       Impact factor: 4.711

4.  Paroxysmal Nocturnal Hemoglobinuria (Pnh): Brain Mri Ischemic Lesions In Neurologically Asymtomatic Patients.

Authors:  Wilma Barcellini; Elisa Scola; Silvia Lanfranconi; Marika Grottaroli; Francesca Binda; Bruno Fattizzo; Anna Zaninoni; Gloria Valcamonica; Claudia Maria Cinnante; Carla Boschetti; Massimiliano Buoli; Carlo Alfredo Altamura; Nereo Bresolin; Fabio Triulzi; Alberto Zanella; Agostino Cortelezzi
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

5.  Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation.

Authors:  Lukas Laurids Goede; Henning Pflugrad; Birte Schmitz; Heinrich Lanfermann; Anita Blanka Tryc; Hannelore Barg-Hock; Jürgen Klempnauer; Karin Weissenborn; Xiao-Qi Ding
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

6.  Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome.

Authors:  Ramona Schuppner; Justus Maehlmann; Meike Dirks; Hans Worthmann; Anita B Tryc; Kajetan Sandorski; Elisabeth Bahlmann; Jan T Kielstein; Anja M Giesemann; Heinrich Lanfermann; Karin Weissenborn
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.